COLAPIETRO, ALESSANDRO
 Distribuzione geografica
Continente #
NA - Nord America 722
EU - Europa 457
AS - Asia 152
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 2
Totale 1.335
Nazione #
US - Stati Uniti d'America 721
IE - Irlanda 192
CN - Cina 99
DE - Germania 77
IT - Italia 58
SE - Svezia 46
TR - Turchia 37
UA - Ucraina 35
GB - Regno Unito 20
VN - Vietnam 10
FR - Francia 9
BE - Belgio 8
FI - Finlandia 5
IN - India 3
EU - Europa 2
RU - Federazione Russa 2
AL - Albania 1
AT - Austria 1
AU - Australia 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
HK - Hong Kong 1
JP - Giappone 1
NL - Olanda 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
SG - Singapore 1
Totale 1.335
Città #
Chandler 194
Dublin 188
Jacksonville 133
New York 41
Ann Arbor 32
Ashburn 32
Izmir 27
Nanjing 26
Grafing 24
Bremen 23
Lawrence 23
Princeton 23
L'aquila 20
Beijing 19
Wilmington 18
Boardman 13
Dong Ket 10
Brussels 8
Nanchang 8
Woodbridge 8
Falls Church 7
San Mateo 7
Tianjin 7
Dearborn 6
L’Aquila 6
Washington 5
Zhengzhou 5
Changsha 4
Des Moines 4
Jinan 4
Kunming 4
Los Angeles 4
Norwalk 4
Rome 4
Seattle 4
Hebei 3
Milan 3
Tappahannock 3
Cedar Knolls 2
Frankfurt am Main 2
Fremont 2
Garland 2
Guangzhou 2
Hanover 2
Jiaxing 2
Menlo Park 2
Piombino Dese 2
Pune 2
Shanghai 2
Shenyang 2
Termoli 2
Verona 2
Amsterdam 1
Carlentini 1
Casoria 1
Edinburgh 1
Fairfield 1
Hangzhou 1
Houston 1
Irkutsk 1
Mountain View 1
Napoli 1
Ningbo 1
Orange 1
Oslo 1
Pavia 1
Perth 1
San Diego 1
San Francisco 1
San José 1
Shreveport 1
Taizhou 1
Tirana 1
Tokyo 1
Vienna 1
Totale 1.005
Nome #
C-Myc Sustains Transformed Phenotype and Promotes Radioresistance of Embryonal Rhabdomyosarcoma Cell Lines 104
Cyclin D1 silencing suppresses tumorigenicity, impairs DNA double strand break repair and thus radiosensitizes androgenindependent prostate cancer cells to DNA damage 101
The brain-penetrating CXCR4 antagonist, PRX177561, increases the antitumor effects of bevacizumab and sunitinib in preclinical models of human glioblastoma 93
The first-in-class alkylating deacetylase inhibitor molecule tinostamustine shows antitumor effects and is synergistic with radiotherapy in preclinical models of glioblastoma 90
Crocetin and crocin from saffron in cancer chemotherapy and chemoprevention 77
Dual PI3K/mTOR inhibitor, XL765 (SAR245409), shows superior effects to sole PI3K [XL147 (SAR245408)] or mTOR [rapamycin] inhibition in prostate cancer cell models 75
Immunolocalization of Advanced Glycation End Products, Mitogen Activated Protein Kinases, and Transforming Growth Factor-β/Smads in Pelvic Organ Prolapse 70
UniPR1331, a small molecule targeting Eph/ephrin interaction, prolongs survival in glioblastoma and potentiates the effect of antiangiogenic therapy in mice 66
The brain penetrating and dual TORC1/TORC2 inhibitor, RES529, elicits anti-glioma activity and enhances the therapeutic effects of anti-angiogenetic compounds in preclinical murine models 60
The Small Molecule Ephrin Receptor Inhibitor, GLPG1790, Reduces Renewal Capabilities of Cancer Stem Cells, Showing Anti-Tumour Efficacy on Preclinical Glioblastoma Models 56
Dual CXCR4 and E-Selectin Inhibitor, GMI-1359, Shows Anti-Bone Metastatic Effects and Synergizes with Docetaxel in Prostate Cancer Cell Intraosseous Growth 56
Correction: The first-in-class alkylating deacetylase inhibitor molecule tinostamustine shows antitumor effects and is synergistic with radiotherapy in preclinical models of glioblastoma (Journal of Hematology and Oncology (2018) 11(32) DOI: 10.1186/s13045-018-0576-6) 55
Expression of Peroxisome Proliferator-Activated Receptor Alpha (PPARα) in Non-Somatotroph Pituitary Tumours and the Effects of PPARα Agonists on MMQ Cells 55
Increased expression and activity of p75NTR are crucial events in azacitidine-induced cell death in prostate cancer 54
Efficient optimization of pyrazolo[3,4-d]pyrimidines derivatives as c-Src kinase inhibitors in neuroblastoma treatment 53
Can the AGE/RAGE/ERK signalling pathway and the epithelial-to-mesenchymal transition interact in the pathogenesis of chronic rhinosinusitis with nasal polyps? 49
Antitumorigenic Effects of Inhibiting Ephrin Receptor Kinase Signaling by GLPG1790 against Colorectal Cancer Cell Lines in Vitro and in Vivo 47
Dual PI3 K/mTOR inhibition reduces prostate cancer bone engraftment altering tumor-induced bone remodeling 46
ATX-101, a Peptide Targeting PCNA, Has Antitumor Efficacy Alone or in Combination with Radiotherapy in Murine Models of Human Glioblastoma 42
The Botanical Drug PBI-05204, a Supercritical CO2 Extract of Nerium Oleander, Is Synergistic With Radiotherapy in Models of Human Glioblastoma 37
The importance of tumor stem cells in glioblastoma resistance to therapy 34
Multiple Antitumor Molecular Mechanisms Are Activated by a Fully Synthetic and Stabilized Pharmaceutical Product Delivering the Active Compound Sulforaphane (SFX-01) in Preclinical Model of Human Glioblastoma 33
Crocetin extracted from saffron shows antitumor effects in models of human glioblastoma 32
The Botanical Drug PBI-05204, a Supercritical CO2 Extract of Nerium Oleander, Inhibits Growth of Human Glioblastoma, Reduces Akt/mTOR Activities, and Modulates GSC Cell-Renewal Properties 12
Totale 1.397
Categoria #
all - tutte 5.446
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.446


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201940 0 0 0 0 0 0 0 0 0 0 0 40
2019/2020172 25 4 17 5 3 20 32 6 22 17 0 21
2020/2021176 7 19 2 22 18 6 24 0 27 8 27 16
2021/2022176 8 0 21 8 5 31 5 5 14 32 10 37
2022/2023555 29 42 10 76 35 58 0 44 234 2 14 11
2023/2024142 19 5 8 2 19 61 1 8 0 4 9 6
Totale 1.397